I was so grateful for the opportunity to cover last week’s convention in Chicago with @jonathantamari and @agreilingkeane — keep following @bgov for intel in the run-up to November!
Heat prompting slower trains makes me think of the 2019 article I wrote for DCist (rip) about how rising temperatures is one of the threats to our transportation systems: https://t.co/SkDMVedyhu
Congratulations to all the journalists who won #PulitzerPrizes today. They all did great work. But besides awards for breaking news reporting and photography, I think awards should be given for other categories as well. Things like: (1/5)
It's time for one of my favorite alumni volunteer activities: writing welcome notes to newly accepted @williamandmary students (feat. @WMDCCenter and @theflathat shoutouts).
This year, the @WMAlumni sent me 40 notes to hand-write! I'm going to need more green pens...
Interested in nominating yourself or a colleague for @BLaw's annual special report honoring stellar young lawyers? Send us your nominations by 8 p.m. EST on March 18! https://t.co/jODVivIrRl
Ahead of the state of the union, @politico's health team did a check-up on President Biden's promises on health care -- from drug pricing to Covid -- and evaluated how he did. Check it out: https://t.co/OYvVYkeR3R
Honeycrisp apple prices have fallen by roughly 32% in the last year.
That's because orchards planted tons of honeycrisp trees over the past 20 years and supply has surpassed demand.
https://t.co/kE4Brfzis8
@EugeneDaniels2 It's a shame that I can only like this Tweet once. It's also a shame that you still need to remind the haters to keep their opinions to themselves.
Turtlenecks forever!
Anybody laid off from the Wall Street Journal, The Messenger, Insider this week, or any news organization: we have job board with more than 1,000 active openings in all areas of journalism.
DM, comment, email [email protected] for free access. 🙏
Long Covid patient-advocates met with Democratic Senate staffers and White House officials after last week's Senate HELP hearing.
They seek a $1 billion annual ‘moonshot’ to enhance clinical trials and accelerate FDA approval for a long Covid treatment.
https://t.co/fyFmHCzRia